Israel No Longer Wants Astrazeneca COVID-19 Vaccine, Seeks to Send Order Elsewhere

A health worker arranges vials of the Pfizer-BioNtech COVID-19 vaccine at the Clalit Health Services in the Palestinian neighborhood of Beit Hanina, in the Israeli-annexed east Jerusalem on March 2, 2021. (AFP)
A health worker arranges vials of the Pfizer-BioNtech COVID-19 vaccine at the Clalit Health Services in the Palestinian neighborhood of Beit Hanina, in the Israeli-annexed east Jerusalem on March 2, 2021. (AFP)
TT
20

Israel No Longer Wants Astrazeneca COVID-19 Vaccine, Seeks to Send Order Elsewhere

A health worker arranges vials of the Pfizer-BioNtech COVID-19 vaccine at the Clalit Health Services in the Palestinian neighborhood of Beit Hanina, in the Israeli-annexed east Jerusalem on March 2, 2021. (AFP)
A health worker arranges vials of the Pfizer-BioNtech COVID-19 vaccine at the Clalit Health Services in the Palestinian neighborhood of Beit Hanina, in the Israeli-annexed east Jerusalem on March 2, 2021. (AFP)

Israel no longer wants AstraZeneca’s COVID-19 vaccine and is exploring with the company whether a big shipment in the pipeline could be sent elsewhere, Israel’s pandemic coordinator said on Wednesday.

“We are trying to find the best solution. After all, we don’t want (the vaccines) to get here and have to throw them into the trash,” the official, Nachman Ash, told Army Radio, saying Israel’s needs were being met by other suppliers.

In his remarks, Ash made no reference to AstraZeneca’s vaccine having been associated with very rare blood clots in Europe. Many countries there resumed administering it after the European Union’s drug watchdog said benefits outweighed risks, Reuters reported.

Israel cast a wide net last year when trying to secure vaccine doses at the height of the pandemic and pre-ordered from a number of companies.

It largely settled on the Pfizer/BioNTech vaccine, launching one of the world’s swiftest rollouts. COVID-19 infections in Israel have dropped dramatically and the economy has reopened.

Israel is also buying the COVID-19 vaccines from Moderna, which uses a similar messenger RNA (mRNA) technology.

Ash said that with supplies secure through 2022, Israel no longer required the 10 million doses it agreed to purchase from AstraZeneca.

“They can certainly be used in other places in the world. At the moment, we are trying to find, along with the company, the best way to do this,” he said.

“We believe it would be best if they (the vaccines) did not come to Israel and we agree with the company on some sort of way to divert them elsewhere.”

Officials at AstraZeneca had no immediate comment.

Around 81 percent of Israeli citizens or residents over 16 - the age group eligible for the Pfizer/BioNTech vaccine in Israel - have received both doses.

Some 167,000 of the 5.2 million Palestinians in the occupied West Bank and Hamas-run Gaza have had at least one dose of vaccine, with supplies coming in from Israel, Russia, the United Arab Emirates, the global COVAX vaccine-sharing program and China.



US, Iran Agree to Hold 6th Round of Indirect Talks

Vehicles of the Iranian delegation leave an entrance of the Omani embassy in Rome where nuclear talks between Iran and the United States were held (Reuters)
Vehicles of the Iranian delegation leave an entrance of the Omani embassy in Rome where nuclear talks between Iran and the United States were held (Reuters)
TT
20

US, Iran Agree to Hold 6th Round of Indirect Talks

Vehicles of the Iranian delegation leave an entrance of the Omani embassy in Rome where nuclear talks between Iran and the United States were held (Reuters)
Vehicles of the Iranian delegation leave an entrance of the Omani embassy in Rome where nuclear talks between Iran and the United States were held (Reuters)

US President Donald Trump said on Tuesday that Iran’s recent posture in nuclear negotiations has grown “much more aggressive,” just days before the sixth round of indirect talks is set to take place on Sunday in Muscat, Oman.

While Trump said the next round of talks would take place on Thursday, a senior Iranian official and a US official said Thursday was unlikely.

Iran and the US have already held five rounds of talks mediated by Oman. And while Iranian Foreign Ministry spokesperson Esmail Baghaei said Tehran and Washington will hold the newest round of talks in Muscat next Sunday, Iran’s top negotiator, Foreign Minister Abbas Araghchi, will be attending the annual Oslo Forum in Norway on Thursday, his office said.

“The US proposal is not acceptable to us. It was not the result of previous rounds of negotiations. We will present our own proposal to the other side via Oman after it is finalized. This proposal is reasonable, logical, and balanced,” Baghaei said.

“We must ensure before the lifting of sanctions that Iran will effectively benefit economically and that its banking and trade relations with other countries will return to normal,” he added.

Trump said that the next round of talks could make it clear if a nuclear deal is possible to avoid military action.

He told reporters at the White House on Monday that Iran appeared to have rejected a key element of an American proposal aimed at breaking the deadlock in the negotiations over the future of the country’s nuclear program.

“They’re just asking for things that you can’t do,” Trump said at the end of an economic event with business and Wall Street leaders. “They don’t want to give up what they have to give up. You know what that is: They seek enrichment.”

Trump also told reporters: “We can’t have enrichment. We want just the opposite, and so far, they’re not there. I hate to say that, because the alternative is a very, very dire one.”

At the same White House event, Trump said he had a telephone conversation on Monday evening with Israeli Prime Minister Benjamin Netanyahu.

One day prior to his phone call with the Israeli PM, Trump and his entire top foreign policy team huddled in Camp David for hours on Sunday to discuss US strategy on the Iran nuclear crisis and the war in Gaza, two US officials and another source with knowledge told Axios.

A senior US official told Axios the president sees both crises as intertwined and part of a broader regional reality he is trying to shape.

Tehran has defended its right to enrich uranium as “non-negotiable,” while Washington called any Iranian enrichment a “red line.”

Meanwhile, Washington's ambassador to Israel, Mike Huckabee, told Bloomberg on Tuesday that Trump will not allow Iran to enrich uranium. Huckabee said “there’s nothing’s off the table,” when asked whether military action was on the table if negotiations failed.

On Tuesday, Iranian Foreign Minister Abbas Araghchi reiterated criticism of a plan by European powers (France, Germany, the UK) and the US to adopt a resolution at the IAEA meeting that would accuse Tehran of non-compliance with nuclear obligations.

“Any ill-considered and destructive decision in the Board of Governors against Iran will be met with an appropriate response,” Araghchi said during a phone call with Japanese Foreign Minister Takeshi Iwaya.

The Japanese Foreign Ministry then said Iwaya and Araghchi had a candid exchange of views on Iran’s nuclear issue.

“Iwaya emphasized that Japan strongly hopes for a peaceful resolution of the issue and that Iran should not miss the opportunity for an agreement between the United States and Iran,” the Ministry statement said.

In Tehran, Iranian lawmakers said in a statement on Tuesday that the United States and Israel are seeking to turn nuclear talks into a “strategic trap” for Iran.

“The US is not serious in negotiations at all. It has set the goal of talks as imposing its demands and has adopted offensive positions that are diametrically opposed to Iranians' inalienable rights,” the statement from parliamentarians said.

“The only acceptable deal is one that permanently lifts all sanctions with the aim of achieving economic benefits for Iran,” lawmakers added in their statement.